Javad Shahidi

All filings by Javad Shahidi on record concern Centessa Pharmaceuticals plc. In total, 3 filings cover trades dated from 1 July 2022 to 3 October 2022.

No open-market purchase appears, only 2 sales worth €25k. The rest of the record consists of 1 share grant.

On 4 October 2022 came the latest disclosure, an open-market sale for €13k in Centessa Pharmaceuticals plc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.